Related Experiment Videos

Dexamethasone adjunctive therapy for bacterial meningitis in children: a retrospective study in Brazil

A Macaluso1, S Pivetta, R S Maggi

  • 1Instituto Materno Infantil de Pernambuco, Recife, Brazil.

Annals of Tropical Paediatrics
|September 1, 1996
PubMed

Insights

Adding dexamethasone to antibiotic treatment significantly improves outcomes for children aged 6-59 months with bacterial meningitis. This combination therapy reduced mortality and increased recovery rates without long-term complications.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Bacterial meningitis is a serious infection in children.
  • Standard treatment involves antibiotics, but outcomes can be improved.

Purpose of the Study:

  • To evaluate the efficacy of adding dexamethasone to antibiotic treatment for pediatric bacterial meningitis.
  • To assess the impact on case fatality rates and long-term sequelae.

Main Methods:

  • Retrospective analysis of clinical records of 179 children with bacterial meningitis.
  • Comparison between children treated with antibiotics alone (Group 1) and antibiotics plus dexamethasone (Group 2).
  • Analysis of outcomes including case fatality rate and discharge without sequelae, stratified by age and pathogen.

Main Results:

  • Overall case fatality was 19% (14% in Group 2 vs. 24% in Group 1, p=0.09).
  • Discharge without sequelae was 70% in Group 2 vs. 56% in Group 1 (p=0.07).
  • In children aged 6-59 months, dexamethasone addition significantly improved case fatality (11% vs. 25%, p=0.05) and reduced sequelae (73% vs. 52%, p=0.02).
  • For Haemophilus influenzae meningitis, Group 2 showed higher rates of discharge without sequelae (77% vs. 51%, p=0.03).

Conclusions:

  • Dexamethasone combined with antibiotics improves outcomes in children aged 6-59 months with bacterial meningitis.
  • This combination therapy is particularly beneficial for reducing mortality and long-term complications.
  • Further research may support the routine use of dexamethasone in specific pediatric meningitis cases.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...